Reported Q: Q2 2025 Rev YoY: +19.0% EPS YoY: +54.4% Move: -1.96%
Phreesia Inc
0A23.L
$28.50 -1.96%
Exchange LSE Sector Healthcare Industry Medical Equipment Services
Q2 2025
Published: Sep 5, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for 0A23.L

Reported

Report Date

Sep 5, 2024

Quarter Q2 2025

Revenue

102.12M

YoY: +19.0%

EPS

-0.31

YoY: +54.4%

Market Move

-1.96%

Previous quarter: N/A

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $102.12M up 19% year-over-year
  • EPS of $-0.31 increased by 54.4% from previous year
  • Gross margin of 60.5%
  • Net income of -18.01M
  • "N/A" - N/A
0A23.L
Company 0A23.L

Executive Summary

Phreesia delivered solid top-line growth in Q2 2025, with revenue of USD 102.1 million, representing a year-over-year increase of 18.97%. Gross margin remained robust at approximately 60.5%, highlighting the inherent profitability of the core SaaS and payments platform. However, the company continues to incur meaningful operating losses, with operating income of -USD 17.22 million and net income of -USD 18.01 million, driven by elevated research and development and selling, general, and administrative expenses. Net cash generation was positive: operating cash flow USD 11.06 million and free cash flow USD 3.66 million, supporting a strong liquidity position as of quarter-end. Phreesia closed the period with USD 81.8 million in cash and equivalents and a net cash position of about USD 65.3 million, underscored by a favorable current ratio (~1.77) and a solid balance sheet structure (total assets USD 362.2 million; total stockholdersโ€™ equity USD 251.3 million). The business model shows continued momentum in revenue growth and platform adoption, but near-term profitability hinges on achieving operating leverage and margin expansion while maintaining disciplined expense management.

Key Performance Indicators

Revenue
Increasing
102.12M
QoQ: 0.89% | YoY: 18.97%
Gross Profit
Increasing
61.81M
60.53% margin
QoQ: 2.45% | YoY: 11.31%
Operating Income
Increasing
-17.22M
QoQ: 11.32% | YoY: 53.40%
Net Income
Increasing
-18.01M
QoQ: 8.67% | YoY: 51.01%
EPS
Increasing
-0.31
QoQ: 11.43% | YoY: 54.41%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2026 117.26 0.01 +14.8% View
Q1 2026 115.94 -0.07 +14.5% View
Q4 2025 109.68 -0.11 +15.5% View
Q3 2025 106.80 0.65 +16.6% View
Q2 2025 102.12 -0.31 +19.0% View